Category: Products & Tech

Cellnovo

Cellnovo Launches World’s First Mobile-Connected Insulin Pump

British based Cellnovo announced the commercial launch of the its new mobile-connected diabetes management system, and the start of the largest usability trial ever to investigate insulin pump technology for patients with type 1 diabetes. The trial will also be the first in which all clinical data is captured remotely, in real-time, using the mobile data connectivity of the Cellnovo system...
0 Shares
merck logo

FDA Approves Merck’s New Type 2 Diabetes Drug Janumet

The FDA has approved Merck's (MSD) new type 2 diabetes medication, JANUMET(R) XR (sitagliptin and metformin hydrochloride (HCl) extended-release) The new treatment combines sitagliptin, which is the active component of Januvia (sitagliptin), with extended-release metformin...
0 Shares
Lilly - Boehringer - logo

FDA Approves New Type 2 Diabetes Combination Medication Jentadueto

The FDA has approved Eli Lilly and Boehringer Ingelheim's new type 2 diabetes treatment Jentadueto (linagliptin/metformin hydrochloride), which combines DPP-4 inhibitor, linagliptin (the active ingredient in Tradjenta™ (linagliptin) tablets), and metformin in a single tablet...
0 Shares
Amylin logo

FDA Approves Type 2 Diabetes Drug Bydureon

Amylin Pharmaceuticals, Inc. and Alkermes plc received FDA approval for Bydureon, a next generation once-weekly treatment for type 2 diabetes. The drug which received EU approval in June was turned down by the FDA twice during 2010, requesting further testing be conducted...
0 Shares